Resolving Lipid Mediators Maresin 1 and Resolvin D2 Prevent Atheroprogression in Mice

Cited by (228)

Items 101–200 of 228

1. Resolvin D2 and its receptor GPR18 in cardiovascular and metabolic diseases: A promising biomarker and therapeutic target
   Mengmeng Zhao, Zihui Zheng, Zheng Yin, Jishou Zhang, Juan‐Juan Qin, Jun Wan, Menglong Wang · 2023 · Pharmacological Research
2. 13‐Series resolvins mediate the leukocyte‐platelet actions of atorvastatin and pravastatin in inflammatory arthritis
   Mary Ellen Walker, Patricia R. Souza, Romain Alexandre Colas, Jesmond Dalli · 2017 · The FASEB Journal
3. Maresin-1 induces cardiomyocyte hypertrophy through IGF-1 paracrine pathway
   Tri Wahyuni, Arisa Kobayashi, Shota Tanaka, Yoshiaki Miyake, Ayaha Yamamoto, Anton Bahtiar, Shota Mori, Yusuke Kametani, Masashi Tomimatsu, Kotaro Matsumoto et al. · 2021 · American Journal of Physiology-Cell Physiology
4. The Role of Resolvins, Protectins and Marensins in Non-Alcoholic Fatty Liver Disease (NAFLD)
   Dominika Maciejewska, Ewa Stachowska, Viktoria Hawryłkowicz, Laura Stachowska, Piotr Prowans · 2021 · Biomolecules
5. Resolvin D1 blocks H2O2-mediated inhibitory crosstalk between SHP2 and PP2A and suppresses endothelial-monocyte interactions
   Rima Chattopadhyay, Arul Murugan Mani, Nikhlesh Kumar Singh, Gadiparthi N. Rao · 2018 · Free Radical Biology and Medicine
6. Cigarette tar accelerates atherosclerosis progression via RIPK3-dependent necroptosis mediated by endoplasmic reticulum stress in vascular smooth muscle cells
   Xiaoxuan Bai, Ying Wang, Xing Luo, Xiaoyi Bao, Xiuzhu Weng, Yuwu Chen, Shan Zhang, Ying Lv, Xinyu Dai, Ming Ying Zeng et al. · 2024 · Cell Communication and Signaling
7. Maresin‐1 ameliorates hypertensive vascular remodeling through its receptor LGR6
   Zheng Yin, Jishou Zhang, Mengmeng Zhao, Shanshan Peng, Jing Ye, Jianfang Liu, Yao Qun Xu, Shuwan Xu, Wei Dong Pan, Wei Cheng et al. · 2024 · MedComm
8. Specialized pro-resolving mediators in diabetes: novel therapeutic strategies
   Eoin Patrick Brennan, Muthukumar Mohan, Darrell C. Andrews, Madhura Bose, Phillip Kantharidis · 2019 · Clinical Science
9. Protective activities of distinct omega-3 enriched oils are linked to their ability to upregulate specialized pro-resolving mediators
   Agua Sobrino, Mary Ellen Walker, Romain Alexandre Colas, Jesmond Dalli · 2020 · PLoS ONE
10. Lipoxins and synthetic lipoxin mimetics: Therapeutic potential in renal diseases
    Darrell C. Andrews, Catherine Godson · 2021 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
11. Specialized Proresolving Lipid Mediators: A Potential Therapeutic Target for Atherosclerosis
    Juan José Salazar, Daniela Pírela, Manuel Nava, Ana Valéria Castro, Lissé Angarita, Heliana Parra, Samuel Durán‐Agüero, Diana Marcela Rojas-Gómez, Néstor Galbán, Roberto Áñez et al. · 2022 · International Journal of Molecular Sciences
12. Utility of the Specialized Pro-Resolving Mediators as Diagnostic and Prognostic Biomarkers in Disease
    Jesmond Dalli, Esteban A. Gómez, Charlotte Camille Jouvene · 2022 · Biomolecules
13. Role of Inflammatory and Proresolving Mediators in Endothelial Dysfunction
    Ana María Briones, Raquel Hernanz, Ana B. García‐Redondo, Cristina Rodrı́guez, Luis Miguel Blanco‐Colio, Almudena Val‐Blasco, María Jesús Alonso, Mercedes Salaíces · 2025 · Basic & Clinical Pharmacology & Toxicology
14. Resolution of inflammation is disturbed in acute ischemic stroke with diabetes mellitus and rescued by resolvin D2 treatment
    Xin Tang, Lan Liu, Zhijuan Miao, Jiawei Zhang, Xiaolong Cai, Bing–Qiao Zhao, Gefei Chen, Marianne Schultzberg, Yuwu Zhao, Xiuzhe Wang · 2022 · Free Radical Biology and Medicine
15. Can Inflammation-Resolution Provide Clues to Treat Patients According to Their Plaque Phenotype?
    Gabrielle Fredman · 2019 · Frontiers in Pharmacology
16. Resolution-promoting autacoids demonstrate promising cardioprotective effects against heart diseases
    Roddy Hiram · 2022 · Molecular Biology Reports
17. Clinical significance of polyunsaturated fatty acids in the prevention of cardiovascular diseases
    Stanislav Nikolaevich Kotlyarov, Анна Анатольевна Котлярова · 2022 · Frontiers in Nutrition
18. Specialized Pro-resolving Mediators Directs Cardiac Healing and Repair with Activation of Inflammation and Resolution Program in Heart Failure
    Ganesh V. Halade, Bochra Tourki · 2019 · Advances in experimental medicine and biology
19. Resolvin D2/GPR 18 axis ameliorates pressure overload-induced heart failure by inhibiting pro-inflammatory macrophage polarization
    Zihui Zheng, Mengmeng Zhao, Yao Xu, Jishou Zhang, Shanshan Peng, Jianfang Liu, Wei Dong Pan, Zheng Yin, Cheng Wei, Juan‐Juan Qin et al. · 2024 · Journal of Lipid Research
20. The resolvin D2 and omega-3 polyunsaturated fatty acid as a new possible therapeutic approach for inflammatory bowel diseases
    Fábio Henrique Mendonça Chaim, Lívia Bitencourt Pascoal, Marina Moreira de Castro, Bruna Biazon Palma, Bruno Lima Rodrigues, João José Fagundes, Marciane Milanski, Luiz Roberto Lopes, Raquel Franco Leal · 2024 · Scientific Reports
21. Matrix stiffness regulates bone repair by modulating 12-lipoxygenase-mediated early inflammation
    Dongdong Yao, Fangyu Qiao, Chenchen Song, Yonggang Lv · 2021 · Materials Science and Engineering C
22. Resolvin D2 limits atherosclerosis progression via myeloid cell‐GPR18
    Masharh Lipscomb, Sean Walis, Michael Marinello, Hebe Agustina Mena, Katherine C. MacNamara, Matthew R. Spite, Gabrielle Fredman · 2024 · The FASEB Journal
23. Metabolic Reprogramming of Macrophages in Atherosclerosis: Is It All about Cholesterol?
    Laurent Yvan‐Charvet, Stoyan Ivanov · 2020 · Journal of Lipid and Atherosclerosis
24. Effect of diabetes on efferocytosis process
    Ali Asghar Mahmoudi, Ali Ahmadizad Firouzjaei, Fateme Darijani, Jamshid Gholizadeh Navashenaq, Eskandar Taghizadeh, Majid Darroudi, Seyed Mohammad Gheibi Hayat · 2022 · Molecular Biology Reports
25. The Use of Specialized Pro-Resolving Mediators in Biomaterial-Based Immunomodulation
    Ana Beatriz Sousa, Judite Novais Barbosa · 2023 · Journal of Functional Biomaterials
26. Protective Potential of Maresins in Cardiovascular Diseases
    Min Liu, Huixiang He, Lihong Chen · 2022 · Frontiers in Cardiovascular Medicine
27. Omega-3 (n-3) Fatty Acid–Statin Interaction: Evidence for a Novel Therapeutic Strategy for Atherosclerotic Cardiovascular Disease
    Ivana D. Djuricic, Philip C. Calder · 2024 · Nutrients
28. Pro-resolving metabolites: Future of the fish oil supplements
    Asma Maliha, Maisha Tahsin, Tayeba Zaman Fabia, Shaikh Mizanoor Rahman, Mizanur Rahman · 2024 · Journal of Functional Foods
29. Cholesterol crystals increase vascular permeability by inactivating SHP2 and disrupting adherens junctions
    Arul Murugan Mani, Rima Chattopadhyay, Nikhlesh Kumar Singh, Gadiparthi N. Rao · 2018 · Free Radical Biology and Medicine
30. Deciphering the Potential Role of Specialized Pro-Resolving Mediators in Obesity-Associated Metabolic Disorders
    Nahyun Kim, Ha Youn Shin · 2024 · International Journal of Molecular Sciences
31. Prognostic impacts of Lipoxin A4 in patients with acute myocardial infarction: A prospective cohort study
    Runzhen Chen, Jiannan Li, Jinying Zhou, Ying Wang, Xiaoxiao Zhao, Nan Li, Weida Liu, Chen Liu, Peng Zhou, Yi Chen et al. · 2022 · Pharmacological Research
32. Resolving atherosclerosis and Alzheimer disease
    Gabrielle Fredman · 2019 · Nature Reviews Cardiology
33. Pro-resolving lipid mediators as therapeutic leads for cardiovascular diseases
    Yuanyuan Cheng, Jianhui Rong · 2019 · Expert Opinion on Therapeutic Targets
34. Functions of TAM Receptors and Ligands Protein S and Gas6 in Atherosclerosis and Cardiovascular Disease
    Teagan Prouse, Samarpan Majumder, Rinku Majumder · 2024 · International Journal of Molecular Sciences
35. The Ins and Outs of Myeloid Cells in Atherosclerosis
    Ariane Schumski, Carla Winter, Yvonne Döring, Oliver Soehnlein · 2018 · Journal of Innate Immunity
36. Omega-3 polyunsaturated fatty acids modify the inverse association between systemic inflammation and cardiovascular fitness
    Gabrielle Farley, Daniel W. Riggs, Aruni Bhatnagar, Jason L. Hellmann · 2021 · Clinical Nutrition
37. Specialized Pro‐Resolving Mediators as Emerging Players in Cardioprotection: From Inflammation Resolution to Therapeutic Potential
    Anna De Bartolo, Naomi Romeo, Tommaso Angelone, Carmine Rocca · 2025 · Acta Physiologica
38. Pro-resolving lipid mediators in diseases: exploring the molecular basis and clinical implication
    Chaofu Li, Zimu Wang, Yukun Yang, Qiuyan Jiang, Yingying Jiang, Jun Xiao, Li Shen, Wei Wu, Chuanwei Li · 2026 · Molecular Biomedicine
39. The Endothelium as a Hub for Cellular Communication in Atherogenesis: Is There Directionality to the Message?
    K. Howe, M. Cybulsky, Jason E. Fish · 2022 · Frontiers in Cardiovascular Medicine
40. Human Neutrophil Peptide 1 Limits Hypercholesterolemia-induced Atherosclerosis by Increasing Hepatic LDL Clearance
    Nicole Paulin, Yvonne Döring, Sander Kooijman, Xavier Blanchet, Joana R. Viola, Renske de Jong, Manuela Mandl, J.C.M. Hendrikse, Maximilian Schiener, Philipp von Hundelshausen et al. · 2017 · EBioMedicine
41. The Association of Free Fatty Acids and Eicosanoids with the Severity of Depressive Symptoms in Stroke Patients
    Dariusz Kotlęga, Agnieszka Zembroń-Łacny, Monika Gołąb-Janowska, Przemysław Nowacki, Małgorzata Szczuko · 2020 · International Journal of Molecular Sciences
42. Critical Role of Inflammation and Specialized Pro-Resolving Mediators in the Pathogenesis of Atherosclerosis
    Subhapradha Rangarajan, Davit Orujyan, Patrida Rangchaikul, Mohamed M. Radwan · 2022 · Biomedicines
43. Is there a role for specialized pro-resolving mediators in pulmonary fibrosis?
    Thomas H. Thatcher, M.A.T. Freeberg, Y.P.A. Myo, Patricia J. Sime · 2023 · Pharmacology & Therapeutics
44. Cardiac Resolvin D2 ameliorates sepsis-induced cardiomyopathy via inhibiting Caspase-11/GSDMD dependent pyroptosis
    Wen-wu Zhang, Shun-shun Wang, Yang-dong Ding, Xinyi Wu, Ting Chen, Ye Gao, Shengwei Jin, Puhong Zhang · 2024 · Free Radical Biology and Medicine
45. Pro-resolving lipid mediators in the resolution of neointimal hyperplasia pathogenesis in atherosclerotic diseases
    Mohan Satish, Devendra K. Agrawal · 2018 · Expert Review of Cardiovascular Therapy
46. Prostaglandin E2, 9S-, 13S-HODE and resolvin D1 are strongly associated with the post-stroke cognitive impairment
    Dariusz Kotlęga, Barbara Peda, Arleta Drozd, Agnieszka Zembroń-Łacny, Ewa Stachowska, J. Gramacki, Małgorzata Szczuko · 2021 · Prostaglandins & Other Lipid Mediators
47. Specialized Pro-Resolving Mediators Derived from N-3 Polyunsaturated Fatty Acids: Role in Metabolic Syndrome and Related Complications
    Laurent Dubé, Schohraya Spahis, Karelle Lachaîne, Andreanne Lemieux, Hanine Monhem, Sarah-Maude Poulin, Carolane Randoll, Eva Travaillaud, Nour-El-Houda Ould-Chikh, Valérie Marcil et al. · 2022 · Antioxidants and Redox Signaling
48. Bioactive lipids and metabolic syndrome—a symposium report
    Loren M. DeVito, Edward A. Dennis, Barbara B. Kahn, Gerald I. Shulman, Joseph Lee Witztum, Sudeshna Sadhu, Joseph T. Nickels, Matthew R. Spite, Susan S. Smyth, Sarah Spiegel · 2022 · Annals of the New York Academy of Sciences
49. Biomimetic Nanocarriers of Pro‐Resolving Lipid Mediators for Resolution of Inflammation in Atherosclerosis
    Maria Anghelache, Geanina Voicu, Mariana Deleanu, Mihaela Turtoi, Florentina Safciuc, Ruxandra Anton, Delia Boteanu, Ioana Mădălina Fenyo, Ileana Mânduțeanu, Maya Simionescu et al. · 2023 · Advanced Healthcare Materials
50. Resolvin D2 / GPR18 signaling enhances monocytic myeloid‐derived suppressor cell function to mitigate abdominal aortic aneurysm formation
    Paolo Bellotti, Zachary Ladd, Victoria Leroy, Gang Su, Shiven Sharma, Joseph B. Hartman, Jonathan R. Krebs, Chelsea Viscardi, Robert Maile, Lyle L. Moldawer et al. · 2024 · The FASEB Journal
51. Do Changes in Innate Immunity Underlie the Cardiovascular Benefits of Exercise?
    Phillip Chuong, Marcin Wysoczynski, Jason L. Hellmann · 2019 · Frontiers in Cardiovascular Medicine
52. TAM receptors and their ligand-mediated activation: Role in atherosclerosis
    Bishuang Cai, Canan Kasikara · 2020 · International review of cytology
53. Exploiting oxidized lipids and the lipid‐binding GPCRs against cardiometabolic diseases
    Raphael Campos Guimarães, Tiago Tomazini Gonçalves, Luiz Osório Leiria · 2020 · British Journal of Pharmacology
54. Specialized Pro-Resolving Lipid Mediators in Neonatal Cardiovascular Physiology and Diseases
    Andrea Gila-Díaz, Gloria Herranz Carrillo, Pratibha Singh, David Ramiro‐Cortijo · 2021 · Antioxidants
55. DHA, RvD1, RvD5, and MaR1 reduce human coronary arteries contractions induced by PGE2
    Amel Bouhadoun, Hasanga D. Manikpurage, Catherine Deschildre, Sara Zalghout, Marc Dubourdeau, Valérie Urbach, Benoît Ho‐Tin‐Noé, Lydia Deschamps, Jean‐Baptiste Michel, Dan Longrois et al. · 2022 · Prostaglandins & Other Lipid Mediators
56. Insights into the role of the resolvin D2-GPR18 signaling axis in cardiovascular physiology and disease
    Matthew R. Spite, Gabrielle Fredman · 2023 · Advances in pharmacology
57. The Intersection of Genetic Factors, Aberrant Nutrient Metabolism and Oxidative Stress in the Progression of Cardiometabolic Disease
    Andrew J. Butcko, Ashley K. Putman, Emilio P. Mottillo · 2024 · Antioxidants
58. Association between plasma maresin 1 and the risk of atherosclerotic cardiovascular disease in Chinese adults: A community-based cohort study
    Mengyuan Li, Yajun Sun, Bingyue Liu, Yong Q. Xue, Mengya Zhu, Kexin Zhang, Jing Yang, Hongzhan Ding, Yanyu Liang, Hui Zhou et al. · 2024 · Nutrition Metabolism and Cardiovascular Diseases
59. Inflammatory Mechanisms in Atherosclerosis
    Ida Gregersen, Bente Lise Halvorsen · 2018 · InTech eBooks
60. Molecular Immune-Inflammatory Connections between Dietary Fats and Atherosclerotic Cardiovascular Disease: Which Translation into Clinics?
    Elisa Mattavelli, Alberico Luigi Catapano, Andrea Baragetti · 2021 · Nutrients
61. Pro-resolution therapeutics for cardiovascular diseases
    Justin Heinz, Michael Marinello, Gabrielle Fredman · 2017 · Prostaglandins & Other Lipid Mediators
62. Novel n-3 Docosapentaneoic Acid-Derived Pro-resolving Mediators Are Vasculoprotective and Mediate the Actions of Statins in Controlling Inflammation
    Jesmond Dalli, Kimberly Pistorius, Mary Ellen Walker · 2019 · Advances in experimental medicine and biology
63. Involvement of Lipids and Lipid Mediators in Inflammation and Atherogenesis
    Stanislav Nikolaevich Kotlyarov · 2024 · Current Medicinal Chemistry
64. Acute Coronary Syndrome May be Associated with Decreased Resolvin D1-to-Leukotriene B4 Ratio
    Changqing Sun, Wuyang Zheng, Ling Liang, Ziguan Zhang, Zuheng Liu, Wenchao Sun, Jianwei Zhou, Weitong Qiao, Qiang Xie, Rong Tang · 2023 · International Heart Journal
65. Different monocyte phenotypes result in proresolving macrophages in conjugated linoleic acid‐induced attenuated progression and regression of atherosclerosis
    Robyn Bruen, Seán Curley, Sarina Kajani, Gina M. Lynch, Marcella E. O'Reilly, Eugène Dillon, Stephen Fitzsimons, Liberty Mthunzi, Fiona C. McGillicuddy, Orina Belton · 2019 · The FASEB Journal
66. Metabolic Regulators of Vascular Inflammation
    Garrett Fairman, Sabrina Robichaud, Mireille I. Ouimet · 2020 · Arteriosclerosis Thrombosis and Vascular Biology
67. HIF1α activation in dendritic cells under sterile conditions promotes an anti-inflammatory phenotype through accumulation of intracellular lipids
    Elizabeth G. Wood, Claire E. Macdougall, Hazel C. Blythe, Marc Clément, Romain Alexandre Colas, Jesmond Dalli, Federica M. Marelli‐Berg, Maria Paula Longhi · 2020 · Scientific Reports
68. The mechanisms of specialized pro-resolving mediators in pain relief: neuro-immune and neuroglial regulations
    Yu‐Shan Chen, Xuewei Wu, Jiaqi Li, Yuxuan Ren, Miao He, Xiaojie Zhai, Changshun Huang, Xiaowei Chen · 2025 · Frontiers in Immunology
69. Peroxisome proliferator‐activated receptor δ improves the features of atherosclerotic plaque vulnerability by regulating smooth muscle cell phenotypic switching
    Chih‐Feng Lien, Chin‐Sheng Lin, Song‐Kun Shyue, Po‐Shiuan Hsieh, Sy‐Jou Chen, Yi‐Tan Lin, Shu Chien, Min‐Chien Tsai · 2023 · British Journal of Pharmacology
70. Crosstalk between efferocytic myeloid cells and T-cells and its relevance to atherosclerosis
    David Ngai, Santosh Reddy Sukka, Ira A. Tabas · 2024 · Frontiers in Immunology
71. Control of the post-infarct immune microenvironment through biotherapeutic and biomaterial-based approaches
    Shreya S. Soni, Arielle M. D’Elia, Christopher B. Rodell · 2023 · Drug Delivery and Translational Research
72. Resolvin D1 attenuates Ang II-induced hypertension in mice by inhibiting the proliferation, migration and phenotypic transformation of vascular smooth muscle cells by blocking the RhoA/mitogen-activated protein kinase pathway
    Wei Cheng, Jishou Zhang, Shanshan Peng, Jianfang Liu, Yao Qun Xu, Mengmeng Zhao, Shuwan Xu, Wei Dong Pan, Zheng Yin, Zihui Zheng et al. · 2023 · Journal of Hypertension
73. Proresolving Lipid Mediators Restore Balance to the Vulnerable Plaque
    Edward Benjamin Thorp · 2016 · Circulation Research
74. Novel UV‐B Phototherapy With a Light‐Emitting Diode Device Prevents Atherosclerosis by Augmenting Regulatory T‐Cell Responses in Mice
    Toru Tanaka, Naoto Sasaki, Aga Krisnanda, Masakazu Shinohara, Hilman Zulkifli Amin, Sayo Horibe, Ken Ito, Motoaki Iwaya, Atsushi Fukunaga, Ken‐ichi Hirata et al. · 2024 · Journal of the American Heart Association
75. Linking Lipid Metabolism and Immune Function: New Insights into Chronic Respiratory Diseases
    Stanislav Nikolaevich Kotlyarov · 2025 · Pathophysiology
76. Maresin1 can be a potential therapeutic target for nerve injury
    Xichen Wang, Benson O. A. Botchway, Yong Zhang, Min Huang, Xuehong Liu · 2023 · Biomedicine & Pharmacotherapy
77. Resolving inflammation in nonalcoholic steatohepatitis
    Matthew R. Spite · 2019 · Journal of Clinical Investigation
78. Tissue factor targeting peptide enhances nanoparticle binding and delivery of a synthetic specialized pro-resolving lipid mediator to injured arteries
    Elizabeth S. Levy, Alexander S. Kim, Evan C. Werlin, Mian Chen, Brian E. Sansbury, Matthew R. Spite, Tejal Ashwin Desai, Michael S. Conte · 2023 · JVS Vascular Science
79. Decreased plasma lipoxin A4, resolvin D1, protectin D1 are correlated with the complexity and prognosis of coronary heart disease: A retrospective cohort study
    Yunfei Wang, Xue-tao Zhu, Ze-ping Hu · 2025 · Prostaglandins & Other Lipid Mediators
80. Inflammation-resolution signalling in cardiac repair, remodelling, and heart failure
    Ganesh V. Halade, M. Bäck, Vasundhara Kain · 2025 · European Heart Journal Open
81. Inverted U‐Shaped Association of Plasma Resolvin D2 With Atherosclerotic Cardiovascular Disease and the Mediation Effects of Serum Cholesterol: A Chinese Community‐Based Study
    Bingyue Liu, Jin Zhang, Kexin Zhang, Mengyuan Li, Yang Jing, Shujun Gu, Hongzhan Ding, Yanyu Liang, Hui Zhou, Chen Dong · 2024 · Journal of the American Heart Association
82. Proresolving receptor tames inflammation in atherosclerosis
    Hebe Agustina Mena, Matthew R. Spite · 2021 · Journal of Clinical Investigation
83. Anti-Atherogenic Mechanisms and Therapies
    Alex Hudson, Oluwakemi Osarumwense Igiehon, Matthew D. Woolard, Arif Yurdagul · 2025 · Current Atherosclerosis Reports
84. Maresins
    Fernanda Berrocal-Navarrete, Paz Marín-Sanhueza, Ramón Norambuena-González, Matías Quiñones San Martin, Francisca Herrera Vielma, Daniel R. González, Jessica Zúñiga‐Hernández · 2026 · Biomolecules
85. Resolvin D2 limits senescent cell accumulation in atherosclerotic plaques
    Masharh Lipscomb, Ignacia Salfate del Rio, Maya Eid, Allison Rahtes, Grace Martino, Sudeshna Sadhu, Sayeed Khan, Katherine C. MacNamara, Gabrielle Fredman · 2025 · Vascular Pharmacology
86. Potential and Future Therapeutic Applications of Eicosapentaenoic/Docosahexaenoic Acid and Probiotics in Chronic Low-Grade Inflammation
    Amedeo Amedei, Ingrid Lamminpää, Cinzia Parolini · 2025 · Biomedicines
87. Big Fish or No Fish; Eicosapentaenoic Acid and Cardiovascular Disease
    Ira J. Goldberg, Jana Gjini, Edward A A Fisher · 2022 · Endocrinology and Metabolism Clinics of North America
88. Inflammation resolution-based treatment of atherosclerosis using biomimetic nanocarriers loaded with specialized pro-resolving lipid mediators
    Maria Anghelache, Geanina Voicu, Ruxandra Anton, Florentina Safciuc, Delia Boteanu, Mariana Deleanu, Mihaela Turtoi, Maya Simionescu, Ileana Mânduțeanu, Manuela Călin · 2025 · Materials Today Bio
89. Role of long-chain polyunsaturated fatty acids, eicosapentaenoic and docosahexaenoic, in the regulation of gene expression during the development of obesity: a systematic review
    Cristian Sandoval, Karen Nahuelqueo, Luciana Mella, Blanca Recabarren, Vanessa Souza‐Mello, Jorge G. Farías · 2023 · Frontiers in Nutrition
90. Anti-Inflammatory Lipid Mediators from Polyunsaturated Fatty Acids: Insights into their Role in Atherosclerosis Microenvironments
    Hong‐Qin Wang, Yuan Li, Lei Zhang, Mengkai Lü, Chao Li, Yunlun Li · 2025 · Current Atherosclerosis Reports
91. Network analyses reveal new insights into the effect of multicomponent Tr14 compared to single-component diclofenac in an acute inflammation model
    Matti Hoch, Suchi Smita, Konstantin Cesnulevicius, Myron Schultz, David Lescheid, Olaf Wolkenhauer A, Shailendra K. Gupta · 2023 · Journal of Inflammation
92. Liver-derived lipoproteins and inflammation: from pathophysiology to pharmacological targets in metabolic liver disease
    Andrea Baragetti · 2022 · Metabolism and Target Organ Damage
93. Effect of specialized pro-resolving lipid mediators in the regulation of vascular tone and inflammation in human saphenous vein
    Zeynep Çelik, Gülsev Özen, Seynur Sunar, Saygın Türkyılmaz, Gülsüm Türkyılmaz, Ali Aycan Kavala, Önder Teskìn, Birsel Sönmez Uydeş Doğan, Gökçe Topal · 2023 · Prostaglandins & Other Lipid Mediators
94. Fine-tuning inflammation-resolution programs
    Gabrielle Fredman, Sudeshna Sadhu, Nicholas Rymut · 2016 · Current Opinion in Clinical Nutrition & Metabolic Care
95. Fatty acid mediators and the inflammasome
    Frédérik Desmarais, Karl‐F. Bergeron, James Mukasa Ntambi, Éric Rassart, Cathérine Mounier · 2020 · Elsevier eBooks
96. Atherothrombose
    Oliver Soehnlein · 2017 · Herz
97. Pro-resolving Mediators
    William Antônio Gonçalves, Alesandra Côrte Reis Melão, Mauro Martins Teixeira, Bárbara Maximino Rezende, Vanessa Pinho · 2018 · Springer eBooks
98. Promoting resolution in kidney disease
    Ross Doyle, Catherine Godson, Eoin Patrick Brennan · 2019 · Current Opinion in Nephrology & Hypertension
99. Atherosclerosis
    Walter Gottlieb Land · 2020 · Springer eBooks
100. Vascular Bed‐Specific Endothelial Dysfunction and Age‐Dependent Circadian Hypertension in Mice Lacking the Resolvin D2 Receptor GPR18
     Sofie De Moudt, Barbara Sitek, Anna Bar, Marc‐Damien Lourenco‐Rodrigues, Jérémy Lagrange, Frances T. Yen, Stefan Chłopicki, Nathalie Mercier, Magnus Bäck · 2025 · The FASEB Journal